Page last updated: 2024-08-21

diphenylamine and pyrazines

diphenylamine has been researched along with pyrazines in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (66.67)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Bruce, JI	1
Archer, S	1
Alexe, G; Armstrong, SA; Blachly, JS; Byrd, JC; Chu, SH; Cremer, A; Ellegast, JM; Frank, ES; Goodale, A; Häupl, B; Mohr, S; Oellerich, T; Piccioni, F; Pikman, Y; Rao, AV; Robichaud, A; Ross, L; Stegmaier, K; Walker, AR	1

Reviews

2 review(s) available for diphenylamine and pyrazines

Article	Year
New anthelmintics. International journal for parasitology, 1987, Volume: 17, Issue:1 Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Diphenylamine; Helminthiasis; Humans; Isothiocyanates; Ivermectin; Pyrazines; Schistosomicides; Thiocyanates; Thiones; Thiophenes	1987
The chemotherapy of schistosomiasis. Annual review of pharmacology and toxicology, 1985, Volume: 25 Topics: Animals; Chemical Phenomena; Chemistry; Diphenylamine; Humans; Hycanthone; Isothiocyanates; Niridazole; Oxamniquine; Praziquantel; Pyrazines; Schistosomiasis; Schistosomicides; Thiocyanates; Thiones; Thiophenes; Trichlorfon	1985

Other Studies

1 other study(ies) available for diphenylamine and pyrazines

Article	Year
Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia. Cancer discovery, 2020, Volume: 10, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Diphenylamine; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Leukemic; Humans; Indazoles; Leukemia, Myeloid, Acute; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase Kinases; Mutagenesis, Site-Directed; Mutation; Open Reading Frames; Primary Cell Culture; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Pyrazines; Syk Kinase; Xenograft Model Antitumor Assays	2020

Article

Year

Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia.

Cancer discovery, 2020, Volume: 10, Issue:2

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Diphenylamine; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Leukemic; Humans; Indazoles; Leukemia, Myeloid, Acute; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase Kinases; Mutagenesis, Site-Directed; Mutation; Open Reading Frames; Primary Cell Culture; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Pyrazines; Syk Kinase; Xenograft Model Antitumor Assays

2020